ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,407Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 324

$577K Total Retail Price of All Prescriptions

Rank: 75 out of 324

392 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 12,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 616 568 1 2
SIMVASTATIN 511 483 2 1
HYDROCODONE-ACETAMINOPHEN 470 433 S3 3 5
FUROSEMIDE 440 401 4 7
AMLODIPINE BESYLATE 415 403 5 4
POTASSIUM CHLORIDE 385 360 6 8
METOPROLOL TARTRATE 335 335 7 14
OMEPRAZOLE 328 316 8 6
ATORVASTATIN CALCIUM 313 313 9 12
LISINOPRIL 269 269 10 3
WARFARIN SODIUM 255 253 11 10
SERTRALINE HCL 226 226 12 23
HYDROCHLOROTHIAZIDE 222 216 13 11
PANTOPRAZOLE SODIUM 208 195 14 34
ATENOLOL 204 189 15 18
METFORMIN HCL 200 192 16 9
LOSARTAN POTASSIUM 167 156 17 15
DONEPEZIL HCL 148 148 18 25
ALENDRONATE SODIUM 147 139 19 24
BUMETANIDE 143 130 20 82
PRAVASTATIN SODIUM 127 127 21 21
CLOPIDOGREL 125 125 22 38
METOPROLOL SUCCINATE 117 117 23 17
ENALAPRIL MALEATE 116 116 24 57
ALLOPURINOL 112 99 25 27
BENAZEPRIL HCL 112 100 25 75
GABAPENTIN 111 104 27 13
NEXIUM 109 97 28 33
GEMFIBROZIL 107 107 29 93
ETODOLAC 107 107 29 221
TRAMADOL HCL 106 106 31 19
NAMENDA 88 88 32 31
AMLODIPINE BESYLATE-BENAZEPRIL 84 84 33 100
PLAVIX 82 82 34 63
TAMSULOSIN HCL 79 66 35 26
ESCITALOPRAM OXALATE 77 77 36 54
CRESTOR 76 76 37 28
ISOSORBIDE MONONITRATE ER 74 74 38 65
CARVEDILOL 71 66 39 22
ZOLPIDEM TARTRATE 71 60 39 20
LOSARTAN-HYDROCHLOROTHIAZIDE 68 68 41 44
FAMOTIDINE 67 67 42 62
SPIRONOLACTONE 65 59 43 47
RANITIDINE HCL 65 65 43 58
DIOVAN 63 57 45 56
OXYCODONE-ACETAMINOPHEN 61 61 S2 46 97
ADVAIR DISKUS 60 60 47 61
GLIPIZIDE 60 47 47 73
CELEBREX 60 60 47 96
CITALOPRAM HBR 59 59 50 16
OXYCODONE HCL 59 53 S2 50 71
LEVOFLOXACIN 58 53 52 84
TRAZODONE HCL 58 58 52 42
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 55 54 91
MIRTAZAPINE 57 57 54 41
VENLAFAXINE HCL ER 57 57 54 86
JANUMET 57 44 54 239
AMITRIPTYLINE HCL 56 53 R 58 66
DIGOXIN 56 56 58 40
FLUTICASONE PROPIONATE 55 55 60 32
OXYBUTYNIN CHLORIDE 55 45 60 88
LANTUS 53 53 62 39
AMIODARONE HCL 52 52 63 151
CIPROFLOXACIN HCL 51 46 64 55
MELOXICAM 51 51 64 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.